News

Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO

Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares Reaffirms…

2 years ago

aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s…

2 years ago

UpHealth Announces the Removal of Dr. Chirinjeev Kathuria as Co-Chairman of the Board of Directors

Action Taken to Ensure Orderly Functioning of the Board Dr. Avi Katz to Serve as Sole Independent Chairman DELRAY BEACH,…

2 years ago

OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical

Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System™WARSAW, Ind., June 14, 2022…

2 years ago

Hepion Pharmaceuticals Appoints Accomplished Life Sciences Industry Veteran, Dr. Launa J. Aspeslet, as Chief Operating Officer

- Dr. Aspeslet joins the Company to support rencofilstat’s clinical program - EDISON, N.J., June 14, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101

LAVAL, Québec, June 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),…

2 years ago

EDAP holds a Symposium at 6th European Endometriosis Congress

LYON, France, June 14, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,…

2 years ago

Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma

Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively…

2 years ago

NEW Opioids Overdose Response Training to Empower High School Students to Help Save Lives

ACT High School Opioid Overdose Response Training Empowering high school teachers to add theOpioid Overdose Response Training to theirstudents’ lifesaving…

2 years ago

InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions

VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…

2 years ago